Intra-Cellular Therapies FDA news release on Sept. 10 appeared positive. The FDA informed the company that it will not schedule an Advisory Committee meeting in connection with its review of the company’s new drug application (NDA) for Lumateperone for the treatment of schizophrenia. All good, moving ahead,...
Cigna Insider Buying is a rarity. Only one corporate insider had bought shares of the giant health insurer on the open market since 2003. That changed dramatically on Monday, as Cigna (CI) CEO David Cordani disclosed the purchase of 32,509 shares of his company's stock at $155.17....
GE is another Enron, only worse. That's according to forensic accountant Harry Markopolos, famous for raising red flags about Bernie Madoff ’s Ponzi scheme before most anyone else had a clue. Markipolos released a report on Thursday claiming General Electric (GE) has been...
Donald Trump's insider buying history is short, but interesting, given the fact that the former corporate insider is now the 45th President of the United States. It was Monday, Sept. 15, 2008 at 3:08 PM when Donald J. Trump filed a Form 4...
Insiders buy market crashes, backing up the truck if their shares get cheap enough. The smartest fund managers can make their year -- even careers -- acquiring great companies at phenomenal bargains during market crashes. True market crashes are rare--black swans. But garden variety "panics" occur fairly...
Solid Biosciences' private placement featured investments by an all star list of top biotech institutional investors. Cambridge-based Solid Biosciences (SLDB) trades at 1/3 of its January 2018 IPO value. But based on the A-list biotech investors buying shares in the company's July 26 $60...
Twenty-two minutes after regular market hours closed on July 2, an Orbimed Advisors Form 4 relating to Corvus Pharmaceuticals Inc (CRVS) was posted on the SEC's website. The hedge fund, a 10%+ holder and insider in CRVS, disclosed that between June 27 and July 1 it...
Macerich insiders have bought a record $2.8 million of the retail mall developer's stock over the last two months as Macerich (MAC) shares hit seven year lows. A great story needs a great title. And what could be better than "Retail Apocalypse" to capture...
A JC Penny (JCP) insider disclosed on Monday afternoon a nearly $1 million purchase of JCP stock at $0.99 cents. JCP traded at $1.91 as recently as March 12, but in recent weeks speculation has intensified that a bankruptcy filing by the 117-year-old retailer was fast approaching.
A Mellanox (MLNX) insider bought $2.2 million of the Israeli chip designer as fears China will block a proposed merger with Nvidia Corp (NVDA) pushed the price of MLNX well below the buyout price. Stephen Sanghi, a director of Sunnyvale-based Mellanox since February...